Henry Schein, Inc.

HSIC · NASDAQ · USD

Can Henry Schein keep taking dental share and turn its cost and pricing program into durable earnings growth, or do slow market growth and margin dilution cap the gain?

Last 4 earnings calls · through Q2 FY2026

Bull case

  • Dental share gains

    The bull case is that Henry Schein is taking dental share back from rivals after the cyber attack, so its sales growth now outpaces a market that is barely expanding.

  • Value creation savings target

    Management has put a firm deadline and a specific dollar target on its cost and pricing program, and the new chief executive has kept that commitment.

  • Cloud software and AI

    Software subscriptions are growing fast and are almost entirely recurring, and new artificial intelligence tools raise revenue per customer and pull through merchandise sales.

  • Own brand sales mix

    Own brands and exclusive products grow faster than the rest of the portfolio at better margins, so the mix improves even when the underlying market does not.

Bear case

  • Recurring restructuring charges

    The bear case is that earnings growth leans on repeated restructuring, and the company still cannot give a GAAP earnings forecast because it cannot size the charges.

  • Respiratory test seasonality

    Its medical arm sells respiratory tests whose demand swings with the flu season, so a light season removes sales that the company cannot control.

  • Value implant margin dilution

    Faster growth in cheaper value implants and in large dental groups dilutes gross margin, so management now stresses gross profit dollars over margin percentage.

  • Slow dental market growth

    Growth has to come from taking share because the U.S. dental and implant markets expand slowly, and a restructured competitor can answer with its own promotions.

Bull and bear points

Growth & Execution

In short: Sales are accelerating as Henry Schein takes dental share, but a light flu season can cut medical sales.

Bull · 2

  • Sales growth accelerated again in the second quarter of 2026

    The acceleration shows the sales force has recovered from the cyber attack and is winning customers back, not merely holding on to them.

    Q2 FY2026 call

  • The long-term earnings goal now has a named year attached

    Dating the target makes management accountable for a specific year instead of a vague multiyear ambition.

    Tone shiftQ3 FY2025 → Q2 FY2026
Bear · 2

  • Respiratory test softness cut medical distribution growth

    A fifth of the medical segment depends on how sick people get each winter, which makes that segment's growth hard to forecast.

    Q1 FY2026 call

  • Equipment comparisons and scanner price cuts limit growth

    Equipment orders are the most cyclical part of dental distribution, so a soft quarter there can offset steady merchandise growth.

    Q2 FY2026 call

Profitability & Financial Strength

In short: Gross margin is expanding on own brands and cost cuts, while value-implant mix limits margin percentage.

Bull · 2

  • Gross margin expanded in all three segments this quarter

    Margin expansion alongside sales growth is what turns share gains into earnings rather than just revenue.

    Q2 FY2026 call

  • The savings program moved from an outline to a dated run rate

    A dated figure lets outsiders check delivery, and the new chief executive has repeated the commitment on both calls since he arrived.

    Tone shiftQ3 FY2025 → Q4 FY2025
Bear · 2

  • Management now steers by gross profit dollars, not margin percentage

    A distributor that grows profit dollars on a flat margin percentage needs more volume to lift earnings, which puts the weight on sales execution.

    Tone shiftQ3 FY2025 → Q2 FY2026

  • Restructuring charges recur and GAAP guidance is still withheld

    Recurring charges make reported profit hard to compare across years and leave the adjusted numbers doing most of the work.

    Q2 FY2026 call

Market Position

In short: Henry Schein supplies most national dental groups and gains share, but those large buyers press on price.

Bull · 2

  • Primary distributor position with national dental groups

    As dental practices consolidate, the share of the market buying through large groups rises, and Henry Schein already sits inside most of them.

    Q1 FY2026 call

  • Merchandise price increases are holding without losing volume

    Passing on cost inflation without losing customers protects gross profit as tariffs and oil prices move.

    Q1 FY2026 call
Bear · 2

  • Large dental groups test pricing on every contract

    The customers that drive the fastest growth also have the most negotiating power, so share gains can come at the cost of price.

    Q3 FY2025 call

  • U.S. dental and implant markets are growing slowly

    When the market barely grows, every point of share gain is contested and harder to repeat once the easiest customers have been won back.

    Q4 FY2025 call